arrow
J

Jacek Legutko

jagiellonian university medical college
H指数:25
被引数:3,954

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biodegradable polymer sirolimus-eluting or durable polymer zotarolimus-eluting stents in high bleeding-risk patients with acute coronary syndrome: the BIOFLOW-DAPT randomized trial

在急性冠脉综合征高风险出血患者中使用可降解聚合物西罗莫司洗脱支架或持久聚合物卓他莫司洗脱支架:BIOFLOW-DAPT随机试验

2026-08-050
PRE
Validated 1-year mortality prediction in patients with three-vessel disease undergoing contemporary percutaneous coronary intervention: insights from the Multivessel TALENT trial

当代经皮冠状动脉介入治疗的三支血管病变患者1年死亡率预测的验证:来自多支血管TALENT试验的见解

2026-07-280
OAAI
Safety and short-term efficacy of mitral transcatheter edge-to-edge repair procedures with MitraClip device: 10-year, single-center, Polish experience

经导管二尖瓣边缘对边缘修复术(MitraClip装置)的安全性及短期疗效:波兰单中心10年经验

2026-01-010
PRE
Pathogenesis of Acute Coronary Syndromes in Patients After COVID-19: An Optical Coherence Tomography Study

COVID-19后患者急性冠状动脉综合征的发病机制:一项光学相干断层扫描研究

2025-12-170
OAAI
Procedural characteristics and outcomes of patients undergoing Impella-assisted high-risk percutaneous coronary interventions in the IMPELLA-PL registry

经Impella辅助的高危经皮冠状动脉介入治疗患者的程序特征和结局:IMPELLA-PL登记研究

2025-12-011
OAAI
TCT-1221 ReTAVI Registry: Early Outcomes of Redo-TAVI with SAPIEN Platform in a Real-World Prospective Cohort

TCT-1221 ReTAVI 注册研究:真实世界前瞻性队列中采用 SAPIEN 平台进行二次 TAVI 的早期结果

JACC
IF0
2025-10-220
PRE
Regional differences in characteristics of patients with acute coronary syndromes pre- and during Coronavirus-2019 pandemic

Bryniarski, K.; Makowicz, D.; Kleczynski, P.; Nosal, M.; Brzychczy, P.; Mroz, K.; Okarski, M.; Twardosz, J.; Gasior, M.; Legutko, J. 冠状动脉综合征患者在冠状病毒-2019大流行前及期间的区域性特征差异。Am. Heart J. Plus Cardiol. Res. Pract. 2025, 60, 100640. [Google Scholar] [CrossRef]

2025-10-011
OAAI
Short-and long-term outcomes of Impella-protected, high-risk, elective PCI in patients with multivessel coronary disease and low ejection fraction - Polish Impella Registry

Impella支持下高危择期经皮冠状动脉介入治疗(PCI)在多支血管冠状动脉疾病和低射血分数患者中的短期和长期结局——波兰Impella注册研究

2025-06-300
PRE